Format
Sort by
Items per page

Send to

Choose Destination

Best matches for type 2 diabetes helicobacter pylori:

Search results

Items: 1 to 20 of 139

1.

Early gastric cancer successfully treated by endoscopic submucosal resection 1 year after laparoscopic sleeve gastrectomy with duodenal-jejunal bypass.

Seki Y, Kasama K, Tanaka T, Baba S, Ito M, Kurokawa Y.

Asian J Endosc Surg. 2018 Jul 17. doi: 10.1111/ases.12630. [Epub ahead of print]

PMID:
30015399
2.

Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis.

Kountouras J, Polyzos SA, Doulberis M, Zeglinas C, Artemaki F, Vardaka E, Deretzi G, Giartza-Taxidou E, Tzivras D, Vlachaki E, Kazakos E, Katsinelos P, Mantzoros CS.

Metabolism. 2018 Jun 21. pii: S0026-0495(18)30142-2. doi: 10.1016/j.metabol.2018.06.008. [Epub ahead of print] Review.

PMID:
29936174
3.
4.

Non-invasive diagnosis of type 2 diabetes in Helicobacter pylori infected patients using isotope-specific infrared absorption measurements.

Som S, Dutta Banik G, Maity A, Ghosh C, Chaudhuri S, Pradhan M.

Isotopes Environ Health Stud. 2018 Aug;54(4):435-445. doi: 10.1080/10256016.2018.1467414. Epub 2018 Apr 24.

PMID:
29688034
5.

Ethnic differences in infectious burden and the association with metabolic risk factors for cardiovascular disease: a cross-sectional analysis.

Hartog L, van Rooijen MS, Ujčič-Voortman J, Prins M, van Valkengoed IGM.

BMC Public Health. 2018 Feb 22;18(1):276. doi: 10.1186/s12889-018-5162-x.

6.

Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China.

Fan N, Peng L, Xia Z, Zhang L, Wang Y, Peng Y.

Front Microbiol. 2018 Jan 31;9:73. doi: 10.3389/fmicb.2018.00073. eCollection 2018.

7.

Metformin and Helicobacter pylori Infection in Patients With Type 2 Diabetes.

Tseng CH.

Diabetes Care. 2018 Apr;41(4):e42-e43. doi: 10.2337/dc17-2551. Epub 2018 Feb 1. No abstract available.

PMID:
29437699
9.

Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways.

Li Y, Bai W, Zhang X.

Mol Med Rep. 2018 Mar;17(3):3583-3590. doi: 10.3892/mmr.2017.8329. Epub 2017 Dec 20.

10.

[New aspects of Helicobacter pylori infection: Association with metabolic disturbances].

German SV, Bobrovnitsky IP.

Ter Arkh. 2017;89(10):102-107. doi: 10.17116/terarkh20178910102-107. Review. Russian.

PMID:
29171479
11.

Group 2 Innate Lymphoid Cells Are Involved in Skewed Type 2 Immunity of Gastric Diseases Induced by Helicobacter pylori Infection.

Li R, Jiang XX, Zhang LF, Liu XM, Hu TZ, Xia XJ, Li M, Xu CX.

Mediators Inflamm. 2017;2017:4927964. doi: 10.1155/2017/4927964. Epub 2017 Sep 12.

12.

Analysis of the Relationship between Helicobacter pylori Infection and Diabetic Gastroparesis.

Huang J.

Chin Med J (Engl). 2017 Nov 20;130(22):2680-2685. doi: 10.4103/0366-6999.218012.

13.

Male non-insulin users with type 2 diabetes mellitus are predisposed to gastric corpus-predominant inflammation after H. pylori infection.

Yang YJ, Wu CT, Ou HY, Lin CH, Cheng HC, Chang WL, Chen WY, Yang HB, Lu CC, Sheu BS.

J Biomed Sci. 2017 Oct 30;24(1):82. doi: 10.1186/s12929-017-0389-x.

14.

Association of Mannose-Binding Lectin rs1800450 and Tumor Necrotic Factor-α rs1800620 Polymorphism with Helicobacter pylori in Type II Diabetes Mellitus.

Mortazavi E, Eslami B, Aghahosseini P, Ahron F, Amininejad A, Mahmoodi S, Satarpour H, Radmanesh N, Rassi H.

Monoclon Antib Immunodiagn Immunother. 2017 Oct;36(5):236-241. doi: 10.1089/mab.2017.0039.

PMID:
29053425
15.

Study on Clinical Factors Involved in Helicobacter pylori-Uninfected, Undifferentiated-Type Early Gastric Cancer.

Horiuchi Y, Fujisaki J, Ishizuka N, Omae M, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T.

Digestion. 2017 Oct 19;96(4):213-219. doi: 10.1159/000481817. [Epub ahead of print]

PMID:
29050004
16.

Helicobacter pylori Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis.

Li JZ, Li JY, Wu TF, Xu JH, Huang CZ, Cheng D, Chen QK, Yu T.

Gastroenterol Res Pract. 2017;2017:5715403. doi: 10.1155/2017/5715403. Epub 2017 Aug 13. Review.

17.

Anoectochilus roxburghii: A review of its phytochemistry, pharmacology, and clinical applications.

Ye S, Shao Q, Zhang A.

J Ethnopharmacol. 2017 Sep 14;209:184-202. doi: 10.1016/j.jep.2017.07.032. Epub 2017 Jul 26. Review.

PMID:
28755972
18.

H. pylori seroprevalence and risk of diabetes: An ancillary case-control study nested in the diabetes prevention program.

Alzahrani S, Nelson J, Moss SF, Paulus JK, Knowler WC, Pittas AG; Diabetes Prevention Program Research Group.

J Diabetes Complications. 2017 Oct;31(10):1515-1520. doi: 10.1016/j.jdiacomp.2017.05.015. Epub 2017 Jun 3.

PMID:
28739267
19.

Synergistic Effect of Hyperglycemia and Helicobacterpylori Infection Status on Colorectal Adenoma Risk.

Hu KC, Wu MS, Chu CH, Wang HY, Lin SC, Liu SC, Liu CC, Su TH, Chen CL, Liu CJ, Shih SC.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2744-2750. doi: 10.1210/jc.2017-00257.

PMID:
28475740
20.

A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.

Gomez-Rubio P, Rosato V, Márquez M, Bosetti C, Molina-Montes E, Rava M, Piñero J, Michalski CW, Farré A, Molero X, Löhr M, Ilzarbe L, Perea J, Greenhalf W, O'Rorke M, Tardón A, Gress T, Barberá VM, Crnogorac-Jurcevic T, Muñoz-Bellvís L, Domínguez-Muñoz E, Gutiérrez-Sacristán A, Balsells J, Costello E, Guillén-Ponce C, Huang J, Iglesias M, Kleeff J, Kong B, Mora J, Murray L, O'Driscoll D, Peláez P, Poves I, Lawlor RT, Carrato A, Hidalgo M, Scarpa A, Sharp L, Furlong LI, Real FX, La Vecchia C, Malats N; PanGenEU Study Investigators.

Ann Oncol. 2017 Jul 1;28(7):1618-1624. doi: 10.1093/annonc/mdx167.

PMID:
28383714

Supplemental Content

Loading ...
Support Center